SC
NAUT icon

Shay Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

Shay Capital’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,896
Closed -$30.4K – 498
2022
Q4 		$30.4K Buy
+16,896
New +$32.6K 0.01% 244
2022
Q1 		– Sell
-20,627
Closed -$107K – 609
2021
Q4 		$107K Buy
+20,627
New +$110K 0.02% 393

Other funds holding NAUT

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Amazon.com Inc
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Shay Capital's NAUT Position: Q1 2023 in Review

Shay Capital sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 16,896 shares — an estimated $30.4K sold.

Shay Capital first reported a position in NAUT in Q4 2021 and held it in 2 quarters. The position peaked at $107K in Q4 2021. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

  • Shay Capital reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
  • Shay Capital sold 16,896 Nautilus Biotechnolgy shares in Q1 2023, an estimated $30.4K.
  • Shay Capital first reported a position in Nautilus Biotechnolgy in Q4 2021 and held it in 2 quarters.
  • Shay Capital's Nautilus Biotechnolgy position peaked at $107K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.